NUS Form 4: Director Disposes 32,437 Class A Shares, Holdings Remain Indirectly Held
Rhea-AI Filing Summary
Daniel W. Campbell, a director of Nu Skin Enterprises (NUS), reported open-market sales of Class A common stock on 08/29/2025. The filing shows two disposal transactions: 9,046 shares sold at a weighted-average price of $12.12 and 23,391 shares sold at a weighted-average price of $12.10, for total reported disposals of 32,437 shares. After the transactions the report shows 39,216 shares held directly and 53,375 shares held indirectly, including shares held by an irrevocable family trust and by a limited liability company controlled by the reporting person and his spouse.
Positive
- None.
Negative
- Director sold 32,437 shares in open-market transactions, reducing direct holdings reported on the form
- Material portion of holdings held indirectly (53,375 shares) via an irrevocable family trust and an LLC, which may be less liquid from the issuer's perspective
Insights
TL;DR: Director executed multi-lot open-market sales totaling 32,437 NUS shares at ~ $12.10–$12.12 per share.
The sales are reported as routine open-market dispositions across multiple trades at slightly varying prices with weighted-average prices disclosed. Holdings remain both direct and indirect, indicating retained investment exposure via an irrevocable family trust and an LLC. The disclosure is standard for Section 16 insiders and provides full price range transparency for the trades.
TL;DR: Insider disclosed planned or executed disposals with ownership now split between direct and indirect holdings.
The form documents compliance with Section 16 reporting for a director-level insider. Indirect ownership through a family trust and an LLC is explicitly disclosed, which clarifies beneficial ownership structure. No derivative transactions or other compensatory issuances are reported, limiting governance complexity in this filing.